MiniMed Aims to Raise $784 Million in IPO

MiniMed, a company specializing in diabetes management, is planning to raise up to $784 million through an initial public offering (IPO). Bloomberg posted on X that the firm, which is set to be spun off from the health-care giant Medtronic, is preparing for this significant financial move. The IPO is expected to provide MiniMed with the necessary capital to expand its operations and enhance its market presence. This development comes as the company seeks to establish itself as an independent entity in the competitive health-care sector. The funds raised will likely be used to support its growth strategies and innovation in diabetes management solutions.